Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.
Coagulation inhibitors and fibrinolytic parameters were studied in twelve patients on continuous ambulatory peritoneal dialysis (CAPD) and ten patients on haemodialysis (HD). Patients on CAPD exhibited higher levels of ATIII and proteins C and S than those on HD. No significant differences were noted in tPA and PAI levels. Both groups of patients showed higher levels of tPA than controls. Besides, patients on HD had significantly lower levels of ATIII and protein C than controls. PAI levels in both patient groups were similar to those of the controls, but tPA levels were higher in patients than in controls. These results indicate that HD is associated with marked diminution in the circulating levels of coagulation inhibitors. This is in contrast to CAPD patients who showed elevated levels of these inhibitors, despite their significant loss in the dialysate. The finding of enhanced fibrinolysis in both patient groups may be a natural protective mechanism against the development of a thrombotic tendency.
Alwakeel
J
J
Department of Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia.
Gader
A M
AM
Hurieb
S
S
al-Momen
A K
AK
Mitwalli
A
A
Abu Aisha
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D015849:Plasminogen Inactivators / Q000097:blood*; D011486:Protein C / Q000032:analysis*; D017293:Protein S / Q000032:analysis*; D006435:Renal Dialysis / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000097:blood*
D015849:Plasminogen Inactivators; D011486:Protein C; D017293:Protein S; D000990:Antithrombin III; D010959:Tissue Plasminogen Activator